NORML

NOVEMBER 8, 2019

Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 212

Access Marijuana Treatment Legislation 212

Veriheal

JUNE 19, 2023

The prominent players, as explained by the psychedelic market report, include Pfizer, Verrian, GlaxoSmithKline, COMPASS Pathways PLC, MindMed, Janssen Pharmaceuticals PLC, HAVN Life Sciences, Seelos Therapeutics, Field Trip Health, amongst others. Psilocybin and LSD have also worked to treat and prevent migraine and cluster headaches.

Therapy 105

Therapy Treatment Patients Policy 105

Cannabis Law Report

NOVEMBER 23, 2019

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

MMJ Recs

JUNE 26, 2020

Dispensing pharmaceuticals. Nursing practice often involves dispensing pharmaceuticals and providing direct patient care services. A person’s job does not affect whether or not they are entitled to apply for an MMJ card, or whether they are entitled to use medical marijuana to treat a health condition.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

Cannabis Law Report

JULY 21, 2022

Kabir Nath brings decades of experience in the health care industry to his new role, most recently serving as Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co.,

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

United Patients Group

FEBRUARY 7, 2023

Inflammation can lead to a wide range of diseases and conditions, including heart disease, arthritis and cancer. This article will cover some common uses for medical cannabis when treating inflammation or pain along with what other ingredients might be helpful in reducing symptoms related to these conditions!

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. Legalization may expand treatment choices for certain conditions, potentially reducing reliance on traditional pharmaceuticals.

Legalization 52

Legalization Access Programs Education 52

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts. How could we move the focus towards understanding the benefits?

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

The Cannigma

JUNE 1, 2021

Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Some 170 hospitals will participate in the two-year experiment.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

APRIL 21, 2022

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

The Blunt Truth

APRIL 20, 2021

Although not immediately effective, New Mexico and Virginia employers should immediately assess the implications of the laws on their current policies and drug testing practices. Virginia went further by enacting the first law providing employment protections to individuals using cannabis oil. Virginia’s Cannabis Oil Law.

Recreational 77

Recreational Legalization Oil Extraction 77

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. Even though the use of CBD for medicine has the support of the FDA, the methods of extracting CBD and the marketing of CBD products will likely become the subjects of high scrutiny.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. As of February 2019, the Veterinary Medical Board in California still has no official policy on hemp products. Medical Cannabis in California.

Pets 215

Pets Legalization Hemp Extraction 215

NORML

FEBRUARY 29, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act (HR 3884 / S. HI resident? Update : SB 1015 was approved by the House on 2/27/20.

Legislation 147

Legislation Decriminalization Patients Edibles 147

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

DECEMBER 15, 2021

Pharmaceuticals & Medical Devices. Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. Senior Regulatory Affairs Associate. Cann Group Limited. Posted 2d ago.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Dykema (Cannabis Law Blog)

DECEMBER 7, 2022

For example, on December 22, 2020, the FDA issued five warnings letters to companies for selling products containing CBD, all addressing the “illegal marketing of unapproved CBD products claiming to treat medical conditions” and the “impermissible marketing of CBD products as dietary supplements.” [2]

CBD 85

CBD Food Consumption Policy 85

Cannabis Law Report

MARCH 9, 2022

Pharmaceuticals & Medical Devices. Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. Senior Regulatory Affairs Associate. Cann Group Limited. Posted 1d ago.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

The Cannigma

JANUARY 21, 2021

It is often called “the mother of all cannabinoids,” and it holds potential as a treatment for conditions such as diabetes, ALS, and Huntington’s disease, although human studies are seriously lacking. For some conditions, like hypertension, CBG shows potential benefits that CBD doesn’t. Which is better, CBG or CBD?

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

The Joint Blog

DECEMBER 9, 2020

According to a new study that may come as little surprise to cannabis consumers and advocates, older individuals (those 60+) report improved quality of life and reduced pharmaceutical medications following marijuana therapy. National Institute of Health.

Pharmaceutical 26

Pharmaceutical Chronic Pain Conditions Marijuana 26

Cannabis Law Report

JULY 19, 2021

Philip Morris International recently offered £1 billion to buy Vectura Group PLC, the British pharmaceutical company that develops inhaled medical products. The global market for inhalation drug delivery devices is predicted to reach $17.6 billion by 2027. About RYAH Group, Inc.

Therapy 76

Therapy Data Research and Development Events 76

SpeedWeed

APRIL 30, 2021

“With about 30 days left in the legislative session, we are so pleased to see the Texas House advancing meaningful changes to our state’s marijuana laws,” said Heather Fazio, director of Texans for Responsible Marijuana Policy, to Marijuana Moment. Now the focus shifts to the Senate, which has historically been a steep uphill battle.”.

Chronic Pain 52

Chronic Pain Concentrates Conditions Therapy 52

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

United Patients Group

FEBRUARY 2, 2023

The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e., antibiotics). Conclusion The endocannabinoid system is one of the most important systems in our bodies.

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Veriheal

DECEMBER 24, 2021

One of the original authors of the Compassionate Use of Medical Cannabis Pilot Program Act in 2013 (MCPP) — a law that led to the legalization of pharmaceutical-grade cannabis across the state of Illinois — says that growing demand and acceptance of the federally illegal plant has not reduced the risk of job loss.

Legislation 90

Legislation Recreational Patients Cannabis 90

NORML

JANUARY 11, 2019

The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. NY resident? New Mexico.

Legislation 198

Legislation Decriminalization Hemp Patients 198

Cannabis Law Report

FEBRUARY 15, 2019

The Singapore Online Citizen reports… Law & Home Affairs Minister K Shanmugam says that pharmaceutical companies are hiding their intentions behind a smokescreen when it comes to cannabis. These can be administered through pharmaceutical products such as oral solutions and sprays.

Medicine 45

Medicine Pharmaceutical Law Cannabinoids 45

Cannabis Law Report

JANUARY 16, 2020

Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this. About Devonian. Devonian Health Group Inc.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

The Cannigma

AUGUST 29, 2021

The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”. Which conditions medical marijuana may help. Get your medical card now with The Cannigma Medical.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed.

Legislation 164

Legislation Decriminalization Access Patients 164

SpeedWeed

MARCH 13, 2021

Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. The authors note that marijuana policy reform has made cannabis widely available for both medical and recreational.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

JUNE 7, 2019

The farm is run by GW Pharmaceuticals, where around two million cannabis plants have been produced since its opening in 1998. But not everyone suffering from these conditions will be able to access it. Something has finally happened in Sittingbourne. Kent Live Report. It’s location was previously regarded as a secret.

Chronic Pain 40

Chronic Pain Epilepsy Legalization Pharmaceutical 40

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. Norway has not legalized recreational cannabis but typically possession of less than 15 grams is punished with a simple fine. How do Norwegians generally view marijuana?

Legalization 59

Legalization Decriminalization Patients Medicine 59

Cannabis Law Report

FEBRUARY 3, 2022

Nimbus Health is a privately owned, licensed pharmaceutical wholesaler from Germany focusing on medical cannabis in Germany. The closing of the transaction is subject to customary closing conditions. with growth of ~25% in 2021 compared to 2020 and a CAGR of ~55 % since 2017, making Germany one of the largest markets in Europe.

Pharmaceutical 52

Pharmaceutical Events Patients Medicine 52

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

OCTOBER 14, 2021

Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. also known as the Canadian Association of Retired Persons) plays an active role in the creation of policy and legislation that impacts older Canadians.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52